AmpliTech has an effective Form S-3 base prospectus from which it intends to offer these securities registered with the Securities and Exchange Commission (the "SEC") for a proposed rights offering in which it plans to distribute to (a) stockholders and (b) certain warrantholders two transferable Unit Rights to purchase up to the maximum of 8,000,000 units at $4.00 per unit. Each unit will consist of one share of common stock (the "Common Shares") and two short-term rights to purchase additional Common Shares.
Under the rights offering, each stockholder and certain warrantholders as of the record date will receive as a dividend, at no charge, two Unit Rights for each (a) Common Share and (b) each Common Share subject to a Warrant owned on the record date. The distribution of the Unit Rights will occur on or around the record date. The record date for the distribution of the Unit Rights, the expiration dates for the Unit Rights and related short-term rights, and related pricing information will be included in the final prospectus.
Holders who fully exercise their Unit Rights will be entitled to oversubscribe for additional units, if available, that are not purchased by other right holders, subject to potential pro rata allocation of those over-subscription units for which they subscribe in proportion to the total number of over-subscription units.
AmpliTech intends to use the net proceeds of the rights offering to scale domestic manufacturing and operations; advance R&D and product commercialization; deepen vertical integration and supply-chain resilience; engage in strategic partnerships; and support corporate growth initiatives; and for working capital and general corporate purposes. The Company recommends that current shareholders and certain warrantholders notify their broker or financial advisor about the upcoming rights offering to ensure their ability to participate.
The expected calendar for the rights offering is as follows:
Dates
Ownership date (last day to buy AMPG to become Record date holder)
November 7, 2025